title: Effect of genistein on native epithelial tissue from normal individuals and CF patients and on ion channels expressed in Xenopus oocytes.
abstract: The flavonoid genistein has been shown to activate a Cl(-) conductance in various cell types expressing CFTR. We examined if similar effects can be observed when genistein is applied to native ex vivo tissues from human respiratory tract and rectum. We further compared the effects when genistein was applied to oocytes of Xenopus laevis expressing CFTR. In oocytes, both wtCFTR and DeltaF508-CFTR were activated by genistein while both cyclic AMP (K(v)LQT1) and Ca(2+) (SK4) activated K(+) channels were inhibited at high concentrations of genistein. Biopsies from nasal polyps and rectal mucosa were obtained from normal individuals (non-CF) and CF patients and in the presence of amiloride (10 micromol l(-1); mucosal side) the effects of genistein were assessed using a perfused Ussing chamber. In non-CF airway epithelia, genistein (50 micromol l(-1); mucosal side) increased lumen negative I(sc) but had no additional effects on tissues pre-stimulated with IBMX and forskolin (100 micromol l(-1) and 1 micromol l(-1); both sides). In non-CF rectal biopsies, in the presence of amiloride (10 micromol l(-1); mucosal side) and indomethacin (10 micromol l(-1); basolateral side), genistein increased lumen negative I(sc) and enabled cholinergic (carbachol; CCH, 100 micromol l(-1); basolateral side) stimulation of Cl(-) secretion indicating activation of luminal CFTR Cl(-) channels. However, after stimulation with IBMX/forskolin, genistein induced opposite effects and significantly inhibited CCH activated I(sc). In CF airway and intestinal tissues genistein failed to induce Cl(-) secretion. Thus, genistein is able to activate luminal CFTR Cl(-) conductance in non-CF tissues and mutant CFTR in oocytes. However, additional inhibitory effects on basolateral K(+) conductance and missing effects in native CF tissues do not support the use for pharmacological intervention in CF.
authors.affiliation: Universitäts-Kinderklink, Albert-Ludwigs-Universität Freiburg, Mathildenstrabetae 1, 79106 Freiburg, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Mall
authors.forename: A
authors.initials: A
authors.lastname: Wissner
authors.forename: H H
authors.initials: HH
authors.lastname: Seydewitz
authors.forename: M
authors.initials: M
authors.lastname: Hübner
authors.forename: J
authors.initials: J
authors.lastname: Kuehr
authors.forename: M
authors.initials: M
authors.lastname: Brandis
authors.forename: R
authors.initials: R
authors.lastname: Greger
authors.forename: K
authors.initials: K
authors.lastname: Kunzelmann
mesh_terms: D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000293:Adolescent; D000328:Adult; D000368:Aged; D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D002648:Child; D002675:Child, Preschool; D005576:Colforsin / Q000494:pharmacology; D003550:Cystic Fibrosis / Q000503:physiopathology*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000187:drug effects* / Q000235:genetics; D004305:Dose-Response Relationship, Drug; D004848:Epithelium / Q000187:drug effects* / Q000503:physiopathology; D005260:Female; D015870:Gene Expression; D019833:Genistein / Q000494:pharmacology*; D006801:Humans; D007473:Ion Channels / Q000187:drug effects* / Q000235:genetics; D017136:Ion Transport / Q000187:drug effects; D008564:Membrane Potentials / Q000187:drug effects; D008875:Middle Aged; D009154:Mutation; D009296:Nasal Cavity / Q000187:drug effects / Q000503:physiopathology; D009865:Oocytes; D012007:Rectum / Q000187:drug effects / Q000503:physiopathology; D015222:Sodium Channels / Q000187:drug effects; D014981:Xenopus
chemical_list: C505032:CFTR protein, human; D007473:Ion Channels; D015222:Sodium Channels; C093349:cystic fibrosis transmembrane conductance regulator delta F508; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D005576:Colforsin; D000584:Amiloride; D019833:Genistein; D015056:1-Methyl-3-isobutylxanthine